About IEC

Bin Feng

Title: Professor
Email: binfeng@dmu.edu.cn
Major: Biotechnology

Education/Professional Experience

EDUCATION

Sep. 1995-Jul. 1998 Ph.D. in Agronomy, Department of Horticulture, Shenyang Agricultural University, Shenyang

Sep. 1992-Jul. 1995 M.S.inBotany and Plant Genetics,College of Life Science, Liaoning Normal University, Dalian

Sep. 1988-Jul. 1992  B.S. in theCollege of Life Science, Liaoning Normal University, Dalian

PROFESSIONAL EXPERIENCE

Dec. 2013 –present   Professor, Depart of Biotechnology, College of Basic Medical Sciences, Dalian Medical University

Apr. 2009 –Dec. 2013  Associate Professor, College of Basic Medical Sciences, Dalian Medical University

Jul. 2006 –Mar. 2009 Assistant in the Department of Physiology, Graduate School of Medicine and Dentistry, Okayama University

Jul. 2004– Jun. 2006 Researcherin the Department of Bioscience and Biotechnology, Faculty of Engineering, Okayama University

Sep. 2001-Jun. 2004 Associate Professor in theCollege of Life Science of Liaoning Normal University

Senior Scientistin Dalian Institute of Chemical Physics (DICP), Chinese Academy of Sciences

Nov. 1999-Sep. 2001  Postdoctor  in the laboratory of Plant Developmental Molecular Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Science, Beijing

Jul. 1998- Nov. 1999  Lecturer in theCollege of Life Science, Liaoning Normal University

Participation in the Academic Community

1.Chinese society of Biochemistry and molecular biology

2.Chinese Society for Cell Biology

Publication

1. Jiawen Yu, Meihua Guo,Ting Wang, Xiang Li, Dan Wang, Xinying Wang, Qian Zhang, Liang Wang, Yang Zhang, Chunhui Zhao,Bin Feng * Inhibition of cell proliferation, migration, and invasion by a glioma-targeted fusion protein combining the p53 C terminus and MDM2-binding domain, Cell Proliferation,2016,49,79-89

2. Chun-hui Zhao, Cui-li Zhan , Jin-jie Shi,Xi-yan Hou, Bin Feng *,Long-xuan Zhao, Design, synthesis, and biofunctional evaluation of novel pentacyclic triterpenes bearing O-[4-(1-piperazinyl)-4-oxo-butyryl moiety as antiproliferative agents,Bioorganic & Medicinal Chemistry Letters, 2015,25,4500-4504.

3. Zhao C, Xu J, Zhang Y, Zhao L, and Feng B *,Inhibition of human enterovirus 71 replication by pentacyclic triterpenes and their novel synthetic derivatives. 2014,62(8):764-771.

4. Zhao C,Feng B(co-first author),Cao Y,Xie P,Xu J,Pang Y,Liu X,Li Q,Identification and characterisation of ROS modulator 1 in Lampetra japonica. Fish Shellfish Immunol,2013,35(2):278-83.

5. Wang L,Xu J,Zhao C,Zhao L,Feng B *,Antiproliferative, cell-cycle dysregulation effects of novel asiatic acid derivatives on human non-small cell lung cancer cells.Chem Pharm Bull . 2013,61(10):1015-1023. 

6. Feng B,Tomizawa K,Michiue H,Han XJ,Miyatake S,Matsui H. Development of a bifunctional immunoliposome system for combined drug delivery and imaging in vivo. Biomaterials. 2010,31(14):4139-45.

Research Projects/Grants

1. Construction of bifunctional boron-containing immunoliposome and targeted  delivery and imaging to glioma(NSFCgrant no.81071248)

2. Study on construction of dual-targeting and multi-function boron-containing liposome with p53 C terminus and its co-therapy with neutron irradiation on glioma (NSFCgrant no. 81371676)

Admission Plan/Requirements

Ph. D Candidate (2017)

Requirement:1. Experiment techniques in molecular biology.  

2.  Skillful Enalish communication and writing ability .